# Other | Center for Medical Cannabis | Utah Department of Health and Human Services > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/utah-medical-cannabis-guidelines-evidence-based-clinical-use/ > **Published:** 2026-04-04T23:12:19-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:11:58-04:00 > **Clinical Summary:** Explore Utah medical cannabis guidelines offering evidence-based clinical recommendations for safe and effective cannabis use in patient care. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Clinical GuidelinesEvidence-Based Medicine[State Policy](https://cedclinic.com/will-the-coronavirus-force-states-to-legalize-marijuana/)[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Clinical Practice Why This Matters Utah’s evidence-based guidelines represent one of the few state-level attempts to systematically evaluate [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) literature and provide clinical recommendations. This matters because most clinicians lack formal training in cannabis therapeutics and need structured guidance for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. Clinical Summary Utah’s Department of Health has developed evidence-based guidelines for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/), reviewing available literature across multiple conditions and therapeutic applications. The guidelines attempt to categorize evidence strength and provide clinical recommendations where data supports use. However, without access to the specific content, the rigor of their evidence review methodology and the clinical utility of their recommendations cannot be assessed. State-level guidelines vary significantly in quality and evidence standards. Dr. Caplan’s Take “I applaud Utah for attempting systematic evidence review, but the proof is in the methodology and specificity of recommendations. Too many ‘evidence-based’ cannabis guidelines still rely on weak studies or extrapolate beyond what the data actually supports.” Clinical Perspective 🧠 Clinicians should evaluate any state cannabis guidelines critically, examining the underlying evidence quality and methodology used. Look for guidelines that clearly distinguish between strong evidence, limited evidence, and expert opinion. Most importantly, state guidelines should complement, not replace, individualized clinical judgment based on patient-specific factors. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Other%20%7C%20Center%20for%20Medical%20Cannabis%20%7C%20Utah%20Department%20of%20Health%20and%20Human%20Servic...%20%40drcaplan&url=https%3A//medicalcannabis.utah.gov/evidence-based-guidelines/other/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//medicalcannabis.utah.gov/evidence-based-guidelines/other/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Other%20%7C%20Center%20for%20Medical%20Cannabis%20%7C%20Utah%20Department%20of%20Health%20and%20Human%20Servic...%20--%20via%20%40drcaplan.bsky.social%20https%3A//medicalcannabis.utah.gov/evidence-based-guidelines/other/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://medicalcannabis.utah.gov/evidence-based-guidelines/other/](https://medicalcannabis.utah.gov/evidence-based-guidelines/other/) Table of Contents - [FAQ](#FAQ)[What type of clinical relevance does this article have?](#What_type_of_clinical_relevance_does_this_article_have) - [What is the main topic of this news article?](#What_is_the_main_topic_of_this_news_article) - [What key areas does this article cover?](#What_key_areas_does_this_article_cover) - [Why is this article considered noteworthy for clinicians?](#Why_is_this_article_considered_noteworthy_for_clinicians) - [What should healthcare professionals expect from this type of content?](#What_should_healthcare_professionals_expect_from_this_type_of_content) - [Related](#Related) ## FAQ #### What type of clinical relevance does this article have? This article has been classified as having “Notable Clinical Interest” with a relevance rating of #76. It represents emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What is the main topic of this news article? This is a cannabis news article from CED Clinic focusing on medical cannabis developments. The content appears to involve clinical guidelines and evidence-based medicine related to cannabis use. #### What key areas does this article cover? The article covers clinical guidelines, evidence-based medicine, [state policy](https://cedclinic.com/will-the-coronavirus-force-states-to-legalize-marijuana/), and medical cannabis. These topics suggest comprehensive coverage of both clinical and regulatory aspects of medical cannabis. #### Why is this article considered noteworthy for clinicians? The article is tagged as having notable clinical interest, indicating it contains emerging findings or policy developments. This suggests the content may impact clinical practice or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions related to medical cannabis. #### What should healthcare professionals expect from this type of content? Healthcare professionals can expect information about evolving clinical guidelines and evidence-based approaches to medical cannabis. The content is likely to provide updates on policy changes and clinical developments worth monitoring in practice. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Evidence based guidelines | Center for Medical Cannabis | Utah Department of Health and …](https://cedclinic.com/2026-cannabis-clinical-guidelines-utah-medical-cannabis/) Detailed review of Utah's evidence-based guidelines for medical cannabis, providing clinical recommendations and policy insights. [Read the Guidelines](https://cedclinic.com/2026-cannabis-clinical-guidelines-utah-medical-cannabis/) [Cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is more than a scientific pursuit—it's a pathway to better health, informed … Explore how [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) informs clinical practice and policy, advancing patient care and health outcomes. Explore Research [Medical Cannabis Significantly Reduced Use of Opioids and Other Rx Drugs](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) Clinical evidence showing medical cannabis as a potential alternative to opioids and prescription medications. [Learn More](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).